About Repligen India Private Limited
Data last updated:
Repligen India Private Limited is a foreign private limited company based in Bangalore, Karnataka, India, a subsidiary of M/S Spectrum Europe. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 03 March 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U29300KA2016FTC086606. Its GSTIN is 29AAWCS8376C1ZJ (Karnataka).
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹2 Cr. It was formerly known as Spectrumlabs India Private Limited. It is led by directors Vijay David Williams Sugumar and Narasimha Murthy Sathyanarayana.
Its last annual general meeting (AGM) was held on 07 August 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Third Floor Indiqube Courtyard Marriot 2/55 Veranna Palya Hebbal, Bangalore, Karnataka, India – 560045.
As per the financials filed for FY 2025, the company reported a revenue of ₹110.29 Cr, a growth of 48% compared to the previous year. For the same year it recorded a net profit of ₹7.66 Cr (net margin 6.9%) and EBITDA of ₹10.54 Cr (EBITDA margin 9.6%). Revenue has grown at a compounded annual rate (CAGR) of 31% over three years and 72% over five years.
The company has about 21 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Repligen. As per MCA filings, the company has open charges of ₹34.02 Lakh and satisfied charges of ₹34.02 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website repligen.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressThird Floor Indiqube Courtyard Marriot 2/55 Veranna Palya Hebbal, Bangalore, Karnataka, India – 560045
- IndustryHealthcare, Medical Equipment Retail & Distribution
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with Repligen India Private Limited
Repligen India operates one associated brand: Repligen. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Products and services for biologic drug manufacturing are supplied. | repligen.com |
Competitors & Alternatives of Repligen India Private Limited
Brands and companies operating in the same space as Repligen India Private Limited include Sutro Biopharma, Synthego, Avidity Biosciences and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
 Sutro Biopharma | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | United States | 2003 |
 Synthego | CRISPR-engineered cell and gene therapies are developed for research applications. | Redwood City, United States | 2012 |
 Avidity Biosciences | Antibody-siRNA complexes are developed for cancer treatment. | San Diego, United States | 2012 |
 Antheia | Yeast cells are genetically engineered to produce medicinal products. | Palo Alto, United States | 2013 |
 Vividion Therapeutics | Developing novel drugs based on a proteome-wide ligand and target discovery platform | Oceanside, United States | 2016 |
 Korro Bio | RNA-editing technologies are provided for precision medicine applications. | Cambridge, United States | 2018 |
 LifeMine Therapeutics | Developer of novel drugs from fungi via genome mining and recombinant overexpression | Cambridge, United States | 2016 |
 Savara Pharma | Therapeutics for rare respiratory diseases are developed by Savara Pharma. | Austin, United States | 2008 |
 Univercells | Biomanufacturing technologies are supplied for biopharma antibody and vaccine production. | Charleroi, Belgium | 2013 |
 GSK | Developer of pharmaceuticals and vaccines for various therapeutic areas | Brentford, United Kingdom |
Business Activity of Repligen India Private Limited
The main business activity of Repligen India is trade. In detail, this covers retail trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Repligen India Private Limited
Repligen India Private Limited is audited by K.P. Rao & Co for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| K.P. Rao & Co | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Repligen India Private Limited
Repligen India has 2 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vijay David Williams Sugumar | Director | 22 Jun 2022 | 4 Years 3 Months | Current |
| Narasimha Murthy Sathyanarayana | Director | 22 Jul 2024 | 2 Years 2 Months | Current |
Financials of Repligen India Private Limited FY 2025 filings available
Repligen India Private Limited reported revenue of ₹110.29 Cr (up 48% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Repligen India Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 72% over five years, including 48% growth in the latest year. EBITDA rose 24% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Repligen India Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹10.54 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹7.66 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Repligen India Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 6.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Repligen India are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Repligen India Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Repligen India Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Sep 2024 | Hdfc Bank Limited | ₹34.02 Lakh | Satisfied |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Repligen India Private Limited
Repligen India Private Limited has a workforce of 21 employees as of Mar 30, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Repligen India Private Limited
Repligen India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAWCS8376C1ZJ | Karnataka | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Repligen India Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Repligen India Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Repligen India Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Repligen India Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Repligen India Private Limited
Recent News on Repligen India Private Limited
Frequently Asked Questions about Repligen India Private Limited
Repligen India is an active foreign private limited company based in Bangalore, Karnataka, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 03 March 2016 (10+ years old) and is registered under CIN U29300KA2016FTC086606.
Repligen India reported revenue of ₹110.29 Cr for FY 2025 (up 48% YoY).
Repligen India has 2 current directors:
- Vijay David Williams Sugumar - Director
- Narasimha Murthy Sathyanarayana - Director
Repligen India reported a net profit of ₹7.66 Cr (net margin 6.9%) and EBITDA of ₹10.54 Cr (EBITDA margin 9.6%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Repligen India is 31% over three years and 72% over five years. In the latest year (FY 2025) revenue rose 48%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Repligen India is 29AAWCS8376C1ZJ, registered in Karnataka.
The CIN (Corporate Identification Number) of Repligen India is U29300KA2016FTC086606. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Repligen India was incorporated on 03 March 2016, making it 10+ years old. It is registered with the Registrar of Companies, Bangalore.
Repligen India can be reached through the website repligen.com. Its registered office is in Bangalore, Karnataka, India.